Elmo1 Activators

The chemical class of Elmo1 activators encompasses a diverse group of compounds with unique mechanisms of action, each influencing cellular processes related to Elmo1 activation. EHop-016 inhibits Rac GTPases, indirectly modulating signaling pathways involving Elmo1 and potentially activating Elmo1-mediated cellular functions, such as cell migration. NSC23766, a selective Rac1 inhibitor, impacts the downstream signaling cascades associated with Elmo1, promoting potential activation and participation in cellular processes, including cell migration and invasion. ML141, a Cdc42 inhibitor, indirectly influences the signaling pathways involving Elmo1, potentially promoting its activation and engagement in cellular processes related to cytoskeletal dynamics and cell migration. SecinH3, an ARF6 inhibitor, targets ARF6, indirectly modulating pathways linked to Elmo1 activation and potential roles in membrane trafficking and cytoskeletal rearrangement. AZD8186, a dual PI3Kβ/δ inhibitor, modulates the PI3K/Akt pathway, indirectly impacting Elmo1-associated pathways, potentially leading to activation and involvement in cell survival and migration.

ITX3 disrupts the ELMO1/Dock180 interaction, directly modulating Elmo1 activity and potentially activating pathways related to cell migration, phagocytosis, and cytoskeletal rearrangement. EHT 1864, a Rac1 inhibitor, indirectly influences signaling pathways involving Elmo1, promoting potential activation and engagement in cellular processes like cell migration and cytoskeletal dynamics. ArhGEF11 inhibitor specifically targets ArhGEF11, indirectly modulating Rho GTPase activity, including pathways associated with Elmo1, potentially leading to its activation and involvement in cell morphology and migration. Y-27632, a ROCK inhibitor, indirectly influences cellular processes linked to Elmo1, participating in the regulation of Elmo1 activation and potential roles in cell migration and cytoskeletal organization. CASIN, an inhibitor of the Cdc42-specific GEF DOCK8, indirectly modulates Cdc42 activity and signaling pathways involving Elmo1, potentially activating Elmo1-mediated cellular processes like cytoskeletal dynamics and cell migration. ML141, another Cdc42 inhibitor, indirectly influences signaling cascades related to Elmo1, potentially promoting its activation and engagement in cellular processes like cytoskeletal dynamics and cell migration.